ATP1A2 and amyotrophic lateral sclerosis: Together, these data suggest that increased activation of α-adducin/α2-Na+/K+-ATPase complex represents a glial cell-intrinsic mechanism of non-cell autonomous neurodegeneration in ALS and support Atp1a2 as a potential therapeutic target in ALS.